149 related articles for article (PubMed ID: 35070246)
21. Upregulation of serum miR-494 predicts poor prognosis in non-small cell lung cancer patients.
Zhang J; Wang T; Zhang Y; Wang H; Wu Y; Liu K; Pei C
Cancer Biomark; 2018; 21(4):763-768. PubMed ID: 29286916
[TBL] [Abstract][Full Text] [Related]
22. Clinical significance of serum miR-25 in non-small-cell lung cancer.
Li J; Yu M; Liu Z; Liu B
Br J Biomed Sci; 2019 Jul; 76(3):111-116. PubMed ID: 30919763
[No Abstract] [Full Text] [Related]
23. Aberrant expression of microRNA-26b and its prognostic potential in human cervical cancer.
Luo M; Shen D; Wang W; Xian J
Int J Clin Exp Pathol; 2015; 8(5):5542-8. PubMed ID: 26191262
[TBL] [Abstract][Full Text] [Related]
24. Identification of serum miR-30a-5p as a diagnostic and prognostic biomarker in colorectal cancer.
Sun Y; Yang B; Lin M; Yu H; Chen H; Zhang Z
Cancer Biomark; 2019; 24(3):299-305. PubMed ID: 30829615
[TBL] [Abstract][Full Text] [Related]
25. MicroRNA-383-5p acts as a potential prognostic biomarker and an inhibitor of tumor cell proliferation, migration, and invasion in breast cancer.
Zhang J; Kong X; Shi Q; Zhao B
Cancer Biomark; 2020; 27(4):423-432. PubMed ID: 31903982
[TBL] [Abstract][Full Text] [Related]
26. Expression of microRNA-497 and its prognostic significance in human breast cancer.
Wang S; Li H; Wang J; Wang D
Diagn Pathol; 2013 Oct; 8():172. PubMed ID: 24143964
[TBL] [Abstract][Full Text] [Related]
27. Expression Analysis of MicroRNA-222 in Breast Cancer.
Amini S; Abak A; Estiar MA; Montazeri V; Abhari A; Sakhinia E
Clin Lab; 2018 Apr; 64(4):491-496. PubMed ID: 29739090
[TBL] [Abstract][Full Text] [Related]
28. [Expression level of miR-199b in human colorectal cancer tissues and its correlation with clinicopathological features and prognosis of patients].
Ma X; Yuan W; Ma J
Zhonghua Zhong Liu Za Zhi; 2023 Apr; 45(4):330-334. PubMed ID: 37078214
[No Abstract] [Full Text] [Related]
29. MiR-613: a novel diagnostic and prognostic biomarker for patients with esophageal squamous cell carcinoma.
Guan S; Wang C; Chen X; Liu B; Tan B; Liu F; Wang D; Han L; Wang L; Huang X; Wang J; Yao B; Shi J; Chen P; Nesa EU; Song Q; Cheng Y
Tumour Biol; 2016 Apr; 37(4):4383-91. PubMed ID: 26499784
[TBL] [Abstract][Full Text] [Related]
30. MicoRNA-425-5p is a potential prognostic biomarker for cervical cancer.
Sun L; Jiang R; Li J; Wang B; Ma C; Lv Y; Mu N
Ann Clin Biochem; 2017 Jan; 54(1):127-133. PubMed ID: 27166306
[TBL] [Abstract][Full Text] [Related]
31. Clinical response and prognostic significance of serum miR-497 expression in colorectal cancer.
Zou G; Wang R; Wang M
Cancer Biomark; 2019; 25(1):11-18. PubMed ID: 31006664
[TBL] [Abstract][Full Text] [Related]
32. Serum miR-92a-1 is a novel diagnostic biomarker for colorectal cancer.
Shi Y; Liu Z
J Cell Mol Med; 2020 Aug; 24(15):8363-8367. PubMed ID: 32562465
[TBL] [Abstract][Full Text] [Related]
33. Expression Analysis of miR-29b in Malignant and Benign Breast Tumors: A Promising Prognostic Biomarker for Invasive Ductal Carcinoma With a Possible Histotype-Related Expression Status.
Papachristopoulou G; Papadopoulos EI; Nonni A; Rassidakis GZ; Scorilas A
Clin Breast Cancer; 2018 Aug; 18(4):305-312.e3. PubMed ID: 29422258
[TBL] [Abstract][Full Text] [Related]
34. Diagnostic and Prognostic Value of Serum miR-296-5p and miR-28-3p in Human Gastric Cancer.
Guo Y; Cui X; Zhang Y; Ma X; Ren A; Huang H
Cancer Biother Radiopharm; 2023 Mar; 38(2):95-101. PubMed ID: 32898433
[No Abstract] [Full Text] [Related]
35. Increased expression of miR-330-3p: a novel independent indicator of poor prognosis in human breast cancer.
Wang H; Chen SH; Kong P; Zhang LY; Zhang LL; Zhang NQ; Gu H
Eur Rev Med Pharmacol Sci; 2018 Mar; 22(6):1726-1730. PubMed ID: 29630118
[TBL] [Abstract][Full Text] [Related]
36. Investigation of microRNA-155 as a serum diagnostic and prognostic biomarker for colorectal cancer.
Lv ZC; Fan YS; Chen HB; Zhao DW
Tumour Biol; 2015 Mar; 36(3):1619-25. PubMed ID: 25528214
[TBL] [Abstract][Full Text] [Related]
37. Circulating miR-200c as a diagnostic and prognostic biomarker for gastric cancer.
Valladares-Ayerbes M; Reboredo M; Medina-Villaamil V; Iglesias-Díaz P; Lorenzo-Patiño MJ; Haz M; Santamarina I; Blanco M; Fernández-Tajes J; Quindós M; Carral A; Figueroa A; Antón-Aparicio LM; Calvo L
J Transl Med; 2012 Sep; 10():186. PubMed ID: 22954417
[TBL] [Abstract][Full Text] [Related]
38. Downregulation of miR-124 predicts poor prognosis in pancreatic ductal adenocarcinoma patients.
Sun B; Liu X; Gao Y; Li L; Dong Z
Br J Biomed Sci; 2016 Oct; 73(4):152-157. PubMed ID: 27922430
[TBL] [Abstract][Full Text] [Related]
39. The conglomeration of diagnostic, prognostic and therapeutic potential of serum miR-199a and its association with clinicopathological features in epithelial ovarian cancer.
Zuberi M; Khan I; Gandhi G; Ray PC; Saxena A
Tumour Biol; 2016 Aug; 37(8):11259-66. PubMed ID: 26951510
[TBL] [Abstract][Full Text] [Related]
40. Potential value of circulatory microRNA122 gene expression as a prognostic and metastatic prediction marker for breast cancer.
Saleh AA; Soliman SE; Habib MSE; Gohar SF; Abo-Zeid GS
Mol Biol Rep; 2019 Jun; 46(3):2809-2818. PubMed ID: 30835039
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
